Paper Details
- Home
- Paper Details
Ex vivo study of human visceral nociceptors.
Author: AhmedShafi, AzizQasim, BlackshawL Ashley, BoundoukiGeorge, BroadJohn, BulmerDavid C, ChanChristopher, Cibert-GotonVincent, HockleyJames R F, KnowlesCharles H, KungVictor, McGuireCian, PeirisMadusha, ReedDavid, SangerGareth J, ThahaMohamed A
Original Abstract of the Article :
OBJECTIVE: The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. DESIGN: Electrophysi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754853/
データ提供:米国国立医学図書館(NLM)
Unveiling the Secrets of Visceral Pain: A Journey into Human Tissue
The quest for effective visceral analgesics, drugs that relieve pain in internal organs, presents a significant challenge. This research delves into the intricate world of human visceral nociceptors, the nerve endings that detect pain, using an innovative ex vivo approach. The study aims to develop a reliable methodology for studying visceral nociception in human tissue, paving the way for the development of more targeted and effective analgesics.
A Deeper Dive into Visceral Pain: Distinct Populations and Their Responses
The study identifies two distinct populations of visceral afferent fibers: serosal and muscular. The serosal units, potentially responsible for transmitting pain signals, exhibit sensitivity to key algesic mediators, bradykinin and ATP, while the muscular units are largely unresponsive. The research also demonstrates the ability of tegaserod, a drug used to treat irritable bowel syndrome, to attenuate the sensitivity of serosal nociceptors.
Targeting Visceral Pain: A New Frontier in Pain Management
This innovative research paves the way for a deeper understanding of visceral pain mechanisms in humans. It offers a promising platform technology for the identification of new targets for drug development, potentially leading to the development of more effective analgesics with fewer side effects.
Dr. Camel's Conclusion
This study represents a groundbreaking advancement in our understanding of visceral pain. By providing a reliable method for studying human visceral nociceptors, it opens doors for the development of more targeted and effective pain relief solutions. This research is a testament to the power of innovation in addressing complex medical challenges.
Date :
- Date Completed 2017-12-18
- Date Revised 2022-01-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.